EPWCF / Empower Clinics ends Q4 2022 with $193,144 in cash; continues to focus on clinical trial services

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said it has signed a letter of intent (LOI) with Crescita Capital LLC for a C$5 million equity capital f more_horizontal

Empower Clnincs Inc. has released a corporate update covering its developing research and clinical trials divisions.  Last month, Empower subsidiary more_horizontal

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) announced that it has signed another agreement for a principal investigator (PI) at its research and clini more_horizontal

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said its subsidiary, EPW Curesearch LLC, has signed two new research services agreements with leading phys more_horizontal

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has announced an agreement to develop a program for research and clinical trials services with a Dallas, T more_horizontal

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said it has commenced a process to explore and evaluate strategic options to enhance and preserve shareho more_horizontal

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has said its previously announced LOI (letter of intent) to create and operate a Dallas-based Site Manage more_horizontal

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has said it held $193,144 in cash at end-2022 as it announced its interim results for the fourth quarter t more_horizontal